LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence company, announced it has surpassed 1,000 early-stage platform subscribers as it advances development of mobile healthcare applications intended for the Apple App Store and Google Play. The company is building a suite of applications to support telehealth, patient engagement, provider coordination, emergency response, and AI-assisted healthcare, with a focus on underserved markets in Latin America and other emerging regions.
According to the company, the applications are being designed to integrate with its broader digital healthcare infrastructure strategy. Management stated that development, testing, and platform optimization efforts are ongoing, with certain applications being prepared for anticipated future submission to Apple and Google app stores. The company emphasized that the applications remain under active development and have not yet been fully commercialized or broadly deployed, and no assurance can be provided regarding the timing of any public release or regulatory progression.
The milestone of surpassing 1,000 early subscribers reflects continued interest in the LataMed AI healthcare technology ecosystem, according to management. Dr. Kevin Rodan Levy, CEO of LataMed AI Corp., stated: "We are continuing to advance development of our mobile healthcare application ecosystem with the goal of expanding accessibility and healthcare connectivity through both Apple and Android mobile platforms. Surpassing 1,000 early-stage users represents an encouraging milestone as we continue refining and expanding our broader digital healthcare infrastructure initiatives." The company believes that ongoing user engagement will provide valuable operational feedback as development progresses.
LataMed AI's technology initiatives focus on scalable healthcare infrastructure solutions for emerging markets where access to telehealth and digital healthcare tools is limited. The company's platform aims to support remote patient engagement, provider coordination, healthcare analytics, and emergency response integration. For more information, visit https://latamed.ai.
The company also noted that its broader efforts remain subject to regulatory considerations and platform review processes. Forward-looking statements in the press release highlight risks including the ability to implement the business plan, obtain financing, secure regulatory authorizations, and complete development and deployment. The company undertakes no obligation to update forward-looking statements. This announcement is for informational purposes only and does not constitute an offer to sell securities. For more details, review the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
